About this event
- Date and time Thu 17 Oct 2024 from 8:00am to 18 Oct 2024 at 5:15pm
- Location Royal Society of Medicine
- Organised by Partner Symposium, Cleveland Clinic London
Stay at the forefront of cardiovascular disease (CVD) with our two-day seminar bringing together experts from the UK and the US for a state-of-the-art review of the most significant changes, critical updates and recommendations to incorporate into your practice. Attendees can expect updates on cutting-edge science and the implementation of evidence-based guidelines, with the opportunity to network with fellow attendees and renowned speakers. In partnership with Cleveland Clinic’s Heart, Vascular and Thoracic Institute. Free for everyone.
This event is specifically tailored for General Practitioners, Consultant Cardiologists, Cardiac Surgeons, nurses, and other medical professionals involved in managing cardiovascular disease patients. Due to limited availability, we kindly request that only individuals from these professions register.
This conference aims to:
- Apply knowledge to reduce cardiovascular risks through optimal management of dyslipidemia, hypertension, obesity, and diabetes
- Review the key advances in cardiac electrophysiology, including VT ablation, atrial fibrillation, and syncope and describe their implications for clinical care
- Apply evidence-based therapies and consensus guidelines for the diagnosis, evaluation, and management across the entire spectrum of patients with heart failure and cardiomyopathy
- Demonstrate comprehensive, evidence-based care in the evaluation and management of ischemic heart disease, including stable angina
- Identify prognostic considerations and evaluate treatment options for mitral and aortic valve disease
- Summarize the key issues in the diagnosis and management of complex aorta disease
Target Audience
This course is designed for General Practitioners, Consultant Cardiologists, Cardiac Surgeons, nurses, and medical professionals involved in managing patients with cardiovascular disease.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Certificate of Participation
A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.
Faculty Disclosure
The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Integrity and Independence requiring mitigation of all faculty conflicts of interest. Faculty declaring a relevant financial relationship will be identified in the activity syllabus.
Cleveland Clinic is nationally ranked and globally recognised as a world leader in cardiovascular care.
Sponsorship and exhibit
For exhibiting or sponsoring this event, please contact Milena Kachar by emailing kacharm@ccf.org
Follow us on:
Agenda
View the provisional programme 17 October 2024
Registration and breakfast
Welcome and Introduction
Olaf Wendler & Samir Kapadia
SESSION 1: PREVENTION OF CARDIOVASCULAR DISEASE
Chairs: Bernard Prendergast & Venu Menon
Panellists: Joan Pattle & Francesca Pugliese
Case scenario: Clinical presentation and initial assessment
Jessica Bivand
Tools for risk prediction and cardiovascular prevention: UK, European and US guidelines
Michael Papadakis
CT coronary angiography: Seeing is believing
Milind Desai
Beyond statins: New agents, new goals, new targets
Leslie Cho
Obesity, diabetes and cardiorenal risk: New therapies and their implementation
John Deanfield
Hypertension: An old disease with new treatment options
Ian Webb
Case scenario: Management strategy and clinical outcome
Jessica Bivand
Panel discussion and Q&A
Coffee break
SESSION 2: VEXING ISSUES IN DAY-TO-DAY PRACTICE
Chairs: Narbeh Melikian & Amanda Vest
Panellists: Ruth Whitby & Michael Papadakis
Case scenario: Clinical presentation and initial assessment
Artur Kowalczyk
Hormone replacement and the heart: Who, when and how?
Leslie Cho
Competitive sport: Screening of professionals and public for cardiovascular safety
Sanjay Sharma
Cancer and the heart: Curative treatment versus cardiac damage
Raj Sharma
Cancer and the lung: Advances in early detection and minimally invasive treatment
Jeremy Smelt
A long way from the heart: Venous and arterial disease of the legs and feet
Joe Shalhoub & Chung Lim
Case scenario: Management strategy and clinical outcome
Artur Kowalczyk
Panel discussion and Q&A
Lunch
SESSION 3: CORONARY ARTERY DISEASE
Chairs: Simon Kennon & Venu Menon
Panellists: Nick Robinson & Ian Webb
Case scenario: Clinical presentation and initial assessment
Erin Jackson
Optimal detection of coronary artery disease and myocardial ischaemia: An era of multimodality personalized imaging
Milind Desai
Management of stable ischaemic heart disease: Who needs revascularisation in 2024?
Julian Strange
Acute coronary syndromes: Key studies underpinning modern management
Ian Webb
Stents or surgery: Daily decision making for the MDT
Olaf Wendler
Case scenario: Management strategy and clinical outcome
Erin Jackson
Panel discussion and Q&A
Coffee break
SESSION 4: HEART FAILURE
Chairs: Sanjay Sharma & Brian Halliday
Panellists: George Amin-Youseff & Walid Saliba
Case scenario: Clinical presentation and initial assessment
George Amin-Youseff
Beyond echocardiography and BNP: The role of PET and CMR in heart failure diagnosis
Dudley Pennell
Acute heart failure: State of the art
Venu Menon
Chronic heart failure: Introduction and optimisation of guideline-directed medical therapy
Amanda Vest
Common co-morbidities and their management: Frailty, anaemia, sleep apnoea and obesity
Brian Halliday
Hypertrophic cardiomyopathy: Current concepts in diagnosis and management
Milind Desai
Case scenario: Management strategy and clinical outcome
George Amin-Youseff
Panel discussion and Q&A
Close
View the provisional programme 18 October 2024
Breakfast
Welcome and announcements
SESSION 5: HEART RHYTHM MANAGEMENT
Chairs: Oussama Wazni & Sabine Ernst
Panellists: Manav Sohal & Tom Wong
Case scenario: Clinical presentation and initial assessment
Simon Sporton
Atrial arrhythmias: Who needs ablation in 2025?
Matt Wright
Prevention of embolic complications: Optimal anticoagulation and left atrial appendage closure
Walid Saliba
Ventricular arrhythmias: New approaches to diagnosis, assessment and treatment
John Whitaker
Sudden cardiac death: Prediction and prevention
Pier Lambiase
Pacing and lead management: New frontiers
Aldo Rinaldi
Case scenario: Management strategy and clinical outcome
Simon Sporton
Panel discussion and Q&A
Coffee break
SESSION 6: VALVE DISEASE I – DIAGNOSIS AND SURVEILLANCE
Chairs: Brian Griffin & Guy Lloyd
Panellists: Mike Bellamy & Sanjeev Battacharya
Case scenario: Clinical presentation and initial assessment
Vitaly Androshchuk
Aortic stenosis: Challenges in diagnosis and quantification
Bushra Rana
Moderate and asymptomatic severe aortic stenosis: Emerging indications for intervention
Samir Kapadia
Primary mitral regurgitation: Epidemiology, early diagnosis and early referral
Brian Griffin
Secondary and tertiary mitral regurgitation: Imaging is the key to successful management
Jim Newton
Tricuspid regurgitation: Overlooked and under-treated
Sam Dawkins
Case scenario: Management strategy and clinical outcome
Vitaly Androshchuk
Panel discussion and Q&A
Lunch
SESSION 7: VALVE DISEASE II - TRANSCATHETER INTERVENTION AND SURGERY
Chairs: Simon Redwood & Gianluca Lucchese
Panellists: Simon Kennon & Jon Byrne
Case scenario: Clinical presentation and initial assessment
Joseph Okafor
Transcatheter aortic valve implantation: Innovation and evolution
Samir Kapadia
Transcatheter mitral and tricuspid edge-to-edge repair: Lessons from recent trials
Tiffany Patterson
Modern valve surgery: Staying ahead of the game
Marc Gillinov
Multi-valve disease: A surgical perspective
Max Baghai
Concomitant atrial fibrillation: Surgical strategies
Ranjit Deshpande
Case scenario: Management strategy and clinical outcome
Joseph Okafor
Panel discussion and Q&A
Coffee break
SESSION 8: COMPLEX DISEASE OF THE AORTA
Chairs: Olaf Wendler & Marc Gillinov
Panellists: Mark Tyrell & Ranjit Deshpande
Case scenario: Clinical presentation and initial assessment
Helen Thomson
Inherited disease of the aorta: Who needs genetic screening?
Guy Lloyd
Bicuspid aortic valve disease: The role of multimodality imaging
Milind Desai
The root and ascending aorta: Advances in surgery
Olaf Wendler
The arch and thoraco-abdominal aorta: Advances in surgery
Aung Oo
Beyond surgery: Interventional and hybrid approaches
Jason Wilkins
Case scenario: Management strategy and clinical outcome
Helen Thomson
Panel discussion and Q&A
Closing remarks
Bernard Prendergast
Close
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Disclaimers:
Registration for this event will close on 15 October 2024 at 11:30pm (BST). Late registrations will not be accepted.
The agenda is subject to change at any time
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.